4 Sarcoma Clinical Trials in Palo Alto, CA (2026)

Q: How do I join a clinical trial in Palo Alto?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you.

Recruiting Sarcoma Studies in Palo Alto

NCT06023641Recruiting

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

This is a phase II study to determine safety and efficacy of combining liposomal irinotecan with vincristine alternating with VAC in intermediate-risk patients, liposomal irinotecan with temozolomide ...

Palo Alto, CAPHASE2135 participantsSt. Jude Children's Research Hospital

View Study Details

NCT06087861Recruiting

5-Day Preoperative Radiation for Soft Tissue Sarcoma

The purpose of this study is to examine the safety and efficacy of an abbreviated course of preoperative radiation, given over five days, for patients with soft tissue sarcoma of the extremity, trunk ...

Palo Alto, CAPHASE275 participantsStanford University

View Study Details

NCT05734066Recruiting

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

This study is conducted in two phases. The phase 1 portion of the study evaluates the safety, tolerability, pharmacokinetics (PK), recommended phase 2 dose (RP2D), and effectiveness of lurbinectedin m...

Palo Alto, CAPHASE160 participantsJazz Pharmaceuticals

View Study Details

NCT05634369Recruiting

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docet...

Palo Alto, CAPHASE150 participantsNationwide Children's Hospital

View Study Details

About Sarcoma Clinical Trials in Palo Alto

Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.

There are currently 4 sarcoma clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 320 participants. Research is being sponsored by St. Jude Children's Research Hospital, Stanford University, Jazz Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Clinical Trials in Palo Alto — FAQ

Are there sarcoma clinical trials in Palo Alto?

Yes, there are 4 sarcoma clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What sarcoma treatments are being tested?

The 4 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.

Data updated July 18, 2026 from ClinicalTrials.gov